Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

AKBAAKBA
21 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in AKEBIA THERAPEUTICS INC

Yes. Qube Research & Technologies holds 1,779,707 shares of AKBA (Akebia Therapeutics), worth $2M, as of its Q2 2026 13F filing. It reduced the position by 615,508 shares (-25.7%) from Q1 2026. Qube Research & Technologies has held AKBA since Q2 2023, across 13 quarterly 13F filings.

Current Value

$2M

Current Shares

1.8M

Total Value Change

+$1.7M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.8M
-25.7%
$2M0.0%$1.14
0
2026-Q1
Decreased
2.4M
-19.9%
$3.3M0.0%$1.22
0
2025-Q4
Decreased
3M
-6.7%
$4.8M0.0%$1.59
0
2025-Q3
Increased
3.2M
+87.0%
$8.8M0.0%$2.71
43
2025-Q2
Increased
1.7M
+60.5%
$6.2M0.0%$3.65
39
2025-Q1
Decreased
1.1M
-10.3%
$2.1M0.0%$1.91
0
2024-Q4
Decreased
1.2M
-10.0%
$2.3M0.0%$1.85
0
2024-Q3
Decreased
1.3M
-24.1%
$1.7M0.0%$1.33
0
2024-Q2
Decreased
1.7M
-22.9%
$1.8M0.0%$1.02
0
2024-Q1
Increased
2.3M
+779.8%
$4.1M0.0%$1.83
43
2023-Q4
Increased
257,173
+111.8%
$318,8950.0%$1.24
38
2023-Q3
Decreased
121,416
-72.2%
$138,4140.0%$1.14
0
2023-Q2
New
436,269
-
$399,1860.0%$0.93
33
2023-Q1
Exited
0
-100.0%
$00.0%$0.56
0
2022-Q4
Decreased
14,855
-92.9%
$8,5710.0%$0.58
0
2022-Q3
Decreased
209,755
-65.0%
$66,0000.0%$0.30
0
2022-Q2
New
598,379
-
$211,0000.0%$0.38
32
2021-Q3
Exited
0
-100.0%
$00.0%$2.86
0
2021-Q2
New
41,564
-
$158,0000.0%$3.86
31
2020-Q3
Exited
0
-100.0%
$00.0%$2.39
0
2020-Q2
New
21,616
-
$294,0000.0%$12.70
32

Other major holders of AKBA: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used